In the majority of cancers, EFNA1, EFNA2, EFNA3, and EFNA4 were suppressed by stromal and/or immune components, whereas EFNA5 demonstrated different trends in the stromal and immune scores across different cancers. Here, EFNA1 is linked to cancer.